Cellectis S.A - 4 Year Stock Price History | CLLS

Historical daily share price chart and data for Cellectis S.A since 2015 adjusted for splits. The latest closing stock price for Cellectis S.A as of August 23, 2019 is 12.10.
  • The all-time high Cellectis S.A stock price is 47.66, which is 293.9% above the current share price.
  • The Cellectis S.A 52-week high stock price is 29.58, which is 144.5% above the current share price.
  • The Cellectis S.A 52-week low stock price is 11.75, which is 2.9% below the current share price.
  • The average Cellectis S.A stock price for the last 52 weeks is 19.60.
Cellectis S.A Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 16.9980 17.1700 20.6000 11.7500 12.1000 -27.33%
2018 28.2993 30.0900 38.5300 15.5800 16.6500 -42.88%
2017 24.5081 18.1200 35.0100 17.5200 29.1500 71.98%
2016 24.5338 30.1600 33.6400 16.4000 16.9500 -45.38%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.520B $0.021B
Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.991B 13.90
Gilead Sciences (GILD) United States $81.332B 9.99
Celgene (CELG) United States $67.834B 10.49
Vertex Pharmaceuticals (VRTX) United States $47.356B 51.18
Biogen (BIIB) United States $42.803B 7.60
Illumina (ILMN) United States $42.421B 49.84
CSL (CSLLY) Australia $36.513B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.402B 14.71
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.690B 14.60
Incyte (INCY) United States $18.401B 54.15
Exact Sciences (EXAS) United States $15.262B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.890B 0.00
Seattle Genetics (SGEN) United States $12.672B 0.00
Genmab (GNMSF) Denmark $12.462B 70.36
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.55
Guardant Health (GH) United States $9.168B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.137B 0.00
Galapagos (GLPG) Belgium $8.509B 0.00
QIAGEN (QGEN) Netherlands $7.794B 25.60
Bio-Techne Corp (TECH) United States $7.250B 50.11
Sarepta Therapeutics (SRPT) United States $7.068B 0.00
BeiGene (BGNE) Cayman Islands $6.835B 0.00
Exelixis (EXEL) United States $6.246B 16.24
Bluebird Bio (BLUE) United States $6.062B 0.00
Amarin (AMRN) Ireland $5.558B 0.00
Horizon Pharma Public (HZNP) Ireland $5.161B 13.12
Ascendis Pharma (ASND) Denmark $4.881B 0.00
Repligen (RGEN) United States $4.775B 92.66
Moderna (MRNA) United States $4.675B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.386B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.220B 0.00
China Biologic Products (CBPO) China $3.897B 24.32
Spark Therapeutics (ONCE) United States $3.897B 0.00
MorphoSys AG (MOR) Germany $3.841B 0.00
Blueprint Medicines (BPMC) United States $3.795B 0.00
Alkermes (ALKS) Ireland $3.358B 0.00
Mirati Therapeutics (MRTX) United States $3.357B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.290B 0.00
Medicines (MDCO) United States $2.840B 0.00
Arena Pharmaceuticals (ARNA) United States $2.742B 5.89
Genomic Health (GHDX) United States $2.741B 51.41
NeoGenomics (NEO) United States $2.679B 143.28
CRISPR Therapeutics AG (CRSP) Switzerland $2.671B 0.00
Immunomedics (IMMU) United States $2.615B 0.00
Amicus Therapeutics (FOLD) United States $2.564B 0.00
MyoKardia (MYOK) United States $2.523B 0.00
Acceleron Pharma (XLRN) United States $2.435B 0.00
Halozyme Therapeutics (HALO) United States $2.411B 0.00
Reata Pharmaceuticals (RETA) United States $2.246B 0.00
Zai Lab (ZLAB) China $2.188B 0.00
Emergent Biosolutions (EBS) United States $2.147B 32.25
UniQure (QURE) Netherlands $2.128B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.059B 0.00
Akcea Therapeutics (AKCA) United States $2.021B 0.00
Cambrex (CBM) United States $1.995B 25.22
Ligand Pharmaceuticals (LGND) United States $1.823B 23.05
Denali Therapeutics (DNLI) United States $1.735B 0.00
Myriad Genetics (MYGN) United States $1.703B 17.87
Coherus BioSciences (CHRS) United States $1.532B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.519B 0.00
Insmed (INSM) United States $1.458B 0.00
Sangamo Therapeutics (SGMO) United States $1.323B 0.00
RA PHARMCTL INC (RARX) United States $1.317B 0.00
REGENXBIO (RGNX) United States $1.291B 0.00
Editas Medicine (EDIT) United States $1.252B 0.00
Epizyme (EPZM) United States $1.209B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.206B 0.00
Fate Therapeutics (FATE) United States $1.204B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.179B 0.00
Athenex (ATNX) United States $1.176B 0.00
Innoviva (INVA) United States $1.154B 3.33
AnaptysBio (ANAB) United States $1.151B 0.00
Alector (ALEC) United States $1.042B 0.00
Zymeworks (ZYME) Canada $0.968B 0.00
Cara Therapeutics (CARA) United States $0.954B 0.00
Twist Bioscience (TWST) United States $0.937B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.910B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.892B 0.00
Principia Biopharma (PRNB) United States $0.841B 438.63
Intellia Therapeutics (NTLA) United States $0.818B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.816B 0.00
Arvinas (ARVN) United States $0.808B 0.00
ANI Pharmaceuticals (ANIP) United States $0.803B 13.40
Cytokineticsorporated (CYTK) United States $0.790B 0.00
Anika Therapeutics (ANIK) United States $0.782B 27.69
Vanda Pharmaceuticals (VNDA) United States $0.777B 28.04
Alder BioPharmaceuticals (ALDR) United States $0.775B 0.00
Vericel (VCEL) United States $0.762B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
WAVE Life Sciences (WVE) Singapore $0.746B 0.00
Codexis (CDXS) United States $0.744B 0.00
Adverum Biotechnologies (ADVM) United States $0.708B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.638B 0.00
Zealand Pharma (ZEAL) Denmark $0.627B 7.28
MiMedx (MDXG) United States $0.624B 0.00
Heska (HSKA) United States $0.588B 76.21
Retrophin (RTRX) United States $0.582B 0.00
Stemline Therapeutics (STML) United States $0.571B 0.00
DBV Technologies S.A (DBVT) France $0.565B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.509B 0.00
PHARMA MAR SA (PHMMF) Spain $0.508B 0.00
Revance Therapeutics (RVNC) United States $0.487B 0.00
Intra-Cellular Therapies (ITCI) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Syros Pharmaceuticals (SYRS) United States $0.460B 0.00
Mesoblast (MESO) Australia $0.459B 0.00
Precision BioSciences (DTIL) United States $0.441B 0.00
UROGEN PHARMA (URGN) United States $0.436B 0.00
Puma Biotechnology (PBYI) United States $0.435B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.426B 0.00
CytomX Therapeutics (CTMX) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.410B 0.00
Agenus (AGEN) United States $0.406B 0.00
BioDelivery Sciences (BDSI) United States $0.396B 0.00
Avid Bioservices (CDMO) United States $0.387B 0.00
AC Immune SA (ACIU) Switzerland $0.377B 27.90
Bellus Health (BLUSD) Canada $0.365B 0.00
Gritstone Oncology (GRTS) United States $0.360B 0.00
Scholar Rock Holding (SRRK) United States $0.355B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.347B 0.00
Kadmon Holdings (KDMN) United States $0.340B 0.00
Protagonist Therapeutics (PTGX) United States $0.330B 0.00
Albireo Pharma (ALBO) United States $0.330B 0.00
Theratechnologies (THERF) Canada $0.327B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Clovis Oncology (CLVS) United States $0.322B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Arcus Biosciences (RCUS) United States $0.312B 0.00
Sorrento Therapeutics (SRNE) United States $0.295B 0.00
Kindred Biosciences (KIN) United States $0.294B 0.00
Prothena (PRTA) Ireland $0.290B 0.00
Dynavax Technologies (DVAX) United States $0.290B 0.00
PDL BioPharma (PDLI) United States $0.289B 7.44
Geron (GERN) United States $0.271B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.265B 0.00
Seres Therapeutics (MCRB) United States $0.263B 0.00
Senesco Technologies (ELOX) United States $0.259B 0.00
ADMA Biologics Inc (ADMA) United States $0.242B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.229B 0.00
PHASEBIO PHARMA (PHAS) United States $0.228B 0.00
Inovio Pharmaceuticals (INO) United States $0.228B 0.00
Cellular Biomedicine (CBMG) United States $0.227B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.224B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
Kamada (KMDA) Israel $0.223B 8.51
Prometic Life Sciences (PFSCF) Canada $0.222B 0.00
Five Prime Therapeutics (FPRX) United States $0.211B 0.00
MannKind (MNKD) United States $0.210B 0.00
Compugen (CGEN) Israel $0.207B 0.00
Athersys (ATHX) United States $0.205B 0.00
Sutro Biopharma (STRO) United States $0.190B 0.00
Cue Biopharma (CUE) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.181B 0.00
Affimed (AFMD) Germany $0.175B 0.00
Dyadic (DYAI) United States $0.174B 0.00
POXEL SA FRANCE (PXXLF) $0.171B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.161B 0.00
Novavax (NVAX) United States $0.159B 0.00
Arsanis (XFOR) United States $0.156B 0.00
Alcobra (ARCT) United States $0.156B 0.00
OSMOTICA PHARM (OSMT) United States $0.156B 0.00
Emmaus Life Sciences (EMMA) United States $0.154B 0.00
Acorda Therapeutics (ACOR) United States $0.153B 0.00
XOMA (XOMA) United States $0.153B 0.00
Cerecor (CERC) United States $0.151B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.151B 0.00
Enzo Biochem (ENZ) United States $0.149B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.145B 0.00
Adocia (ADOCY) France $0.140B 0.00
Strongbridge Biopharma (SBBP) United States $0.138B 5.64
Windtree Therapeutics (WINT) United States $0.133B 0.00
NantKwest (NK) United States $0.131B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.127B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
Mersana Therapeutics (MRSN) United States $0.122B 0.00
Fortress Biotech (FBIO) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.117B 0.00
Northwest Biotherapeutics (NWBO) United States $0.115B 0.00
Checkpoint Therapeutics (CKPT) United States $0.114B 0.00
Menlo Therapeutics (MNLO) United States $0.113B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.111B 0.00
TOCAGEN INC (TOCA) United States $0.108B 0.00
Aduro Biotech (ADRO) United States $0.107B 0.00
Liquidia Technologies (LQDA) United States $0.106B 0.00
Aptinyx (APTX) United States $0.105B 0.00
Abeona Therapeutics (ABEO) United States $0.101B 0.00
Verastem (VSTM) United States $0.100B 0.00
Synlogic (SYBX) United States $0.099B 0.00
OvaScience (MLND) United States $0.097B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.093B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.090B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Antibe Therapeutics (ATBPF) Canada $0.085B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.085B 0.00
Catalyst Biosciences (CBIO) United States $0.085B 0.00
Vaccinex (VCNX) United States $0.084B 0.00
Trevena (TRVN) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Curis (CRIS) United States $0.069B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Idera Pharmaceuticals (IDRA) United States $0.068B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
NewLink Genetics (NLNK) United States $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
VBI Vaccines (VBIV) United States $0.063B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
Prima BioMed (IMMP) Australia $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 30.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
AIT Therapeutics (XAIR) United States $0.053B 0.00
Ophthotech (ISEE) United States $0.048B 0.00
Oncobiologics (OTLK) United States $0.047B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
Apricus Biosciences (SEEL) United States $0.040B 0.00
Signal Genetics (MGEN) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Proteostasis Therapeutics (PTI) United States $0.036B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.031B 0.00
DiaMedica Therapeutics (DMAC) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Vical (VICL) United States $0.019B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.30
Pulmatrix (PULM) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Neuralstem (CUR) United States $0.004B 0.00